117 related articles for article (PubMed ID: 35575394)
21. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
22. Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification.
Durigova A; Lamy PJ; Thezenas S; Pouderoux S; Montels F; Romieu G; Gutowski M; Jacot W
Clin Chem Lab Med; 2013 Sep; 51(9):1833-41. PubMed ID: 23787470
[TBL] [Abstract][Full Text] [Related]
23. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
24. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
25. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
27. [Differential diagnosis of anemia in true and functional iron deficiency in patients with chronic diseases (malignant tumors)].
Zubrikhina GN; Blindar VN; Matveeva II
Ter Arkh; 2016; 88(4):61-67. PubMed ID: 27070165
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.
Jang JH; Kim Y; Park S; Kim K; Kim SJ; Kim WS; Jung CW; Lee J; Lee SH
PLoS Med; 2020 Jun; 17(6):e1003091. PubMed ID: 32511251
[TBL] [Abstract][Full Text] [Related]
29. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
30. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
31. Predictors of anemia and iron status at birth in neonates born to women carrying multiple fetuses.
Ru Y; Pressman EK; Guillet R; Katzman PJ; Bacak SJ; O'Brien KO
Pediatr Res; 2018 Aug; 84(2):199-204. PubMed ID: 29907852
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
33. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
35. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia.
Cheng PP; Jiao XY; Wang XH; Lin JH; Cai YM
Clin Exp Med; 2011 Mar; 11(1):33-42. PubMed ID: 20499129
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
Sany D; El Shahawi Y; Taha J
Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
[TBL] [Abstract][Full Text] [Related]
37. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
38. [The characteristics of anemic syndrome in patients with prevalent phases of Hodgkin lymphoma before treatment].
Zubrikhina GN; Blindar VN; Matveeva II; Demina EA
Klin Lab Diagn; 2015 Feb; 60(2):28-32. PubMed ID: 26027256
[TBL] [Abstract][Full Text] [Related]
39. [The possibilities of modern automated clinical blood analysis in differentiated diagnostic of true and redistributing (functional) iron deficiency under anemic syndrome in oncologic patients].
Zubrikhina GN; Blinder VN; Matveyeva II
Klin Lab Diagn; 2014 May; (5):21-5. PubMed ID: 25338459
[TBL] [Abstract][Full Text] [Related]
40. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
